Ginkgo agrees to $17.5b merger with Harry Sloanâs SPAC By Gillian Tan, Crystal Tse and Kristen V. Brown Bloomberg,Updated May 11, 2021, 7:31 a.m. Email to a Friend An automated fermenting machine at the Ginkgo Bioworks Inc. facility in Boston.Scott Eisen/Bloomberg Ginkgo Bioworks Inc., which calls itself an âorganism designâ company, has agreed to go public in a $17.5 billion merger with a blank-check firm backed by former Hollywood executive Harry Sloan. The Boston-based company, which uses technology to program cells for a potentially wide variety of uses, will combine with Soaring Eagle Acquisition Corp., according to a regulatory filing Tuesday that confirmed an earlier Bloomberg News report.